Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-004201

General Counsel sold 10,800 shares at $7.42 ($80,146)

From the SEC's structured data for this filing

Trades in this filing

MOORE JOHN R · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-16 Sale : show line 1 in the form −10,800 $7.42 $80,146 3,000 D
Open-market sales · 10,800 sh · avg $7.42 · $80,146
Loading xslF345X03/primarydocument.xml…